Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Silvia Arcangeli"'
Autor:
Alice Bergamini, Barbara Camisa, Attilio Bondanza, Fabio Ciceri, Chiara Bonini, Monica Casucci, Beatrice Greco, Camilla Bove, Silvia Arcangeli, Laura Falcone, Rita El Khoury, Anna De Lucia
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background To date, T cells redirected with CD19-specific chimeric antigen receptors (CAR) have gained impressive success in B-cell malignancies. However, treatment failures are common and the occurrence of severe toxicities, such as cytokine release
Externí odkaz:
https://doaj.org/article/f7f0700140a54a238b7f036e7241a8c9
Autor:
Silvia Arcangeli, Camilla Bove, Claudia Mezzanotte, Barbara Camisa, Laura Falcone, Francesco Manfredi, Eugenia Bezzecchi, Rita El Khoury, Rossana Norata, Francesca Sanvito, Maurilio Ponzoni, Beatrice Greco, Marta Angiola Moresco, Matteo G. Carrabba, Fabio Ciceri, Chiara Bonini, Attilio Bondanza, Monica Casucci
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 12 (2022)
Chimeric antigen receptor (CAR) T cell expansion and persistence represent key factors to achieve complete responses and prevent relapses. These features are typical of early memory T cells, which can be highly enriched through optimized manufacturin
Externí odkaz:
https://doaj.org/article/81d1da4c079b452abf38886ebf969f0d
Autor:
Silvia Arcangeli, Laura Falcone, Barbara Camisa, Federica De Girardi, Marta Biondi, Fabio Giglio, Fabio Ciceri, Chiara Bonini, Attilio Bondanza, Monica Casucci
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Chimeric antigen receptor (CAR) T cell expansion and persistence emerged as key efficacy determinants in cancer patients. These features are typical of early-memory T cells, which can be enriched with specific manufacturing procedures, providing sign
Externí odkaz:
https://doaj.org/article/566b2b6edfac40ce85ed4f163b8a2092
Autor:
Sarah Tettamanti, Maria Caterina Rotiroti, Greta Maria Paola Giordano Attianese, Silvia Arcangeli, Ronghua Zhang, Priyanka Banerjee, Giovanni Galletti, Sheighlah McManus, Massimiliano Mazza, Fabio Nicolini, Giovanni Martinelli, Cristina Ivan, Tania Veliz Rodriguez, Federica Barbaglio, Lydia Scarfò, Maurilio Ponzoni, William Wierda, Varsha Gandhi, Michael Keating, Andrea Biondi, Federico Caligaris-Cappio, Ettore Biagi, Paolo Ghia, Maria Teresa Sabrina Bertilaccio
Publikováno v:
Leuk Lymphoma
Chimeric antigen receptors (CAR)-modified T cells are an emerging therapeutic tool for chronic lymphocytic leukemia (CLL). However, in patients with CLL, well-known T-cell defects and the inhibitory properties of the tumor microenvironment (TME) hind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11faa507989fbd3be0e116d940d6dc27
https://europepmc.org/articles/PMC9828187/
https://europepmc.org/articles/PMC9828187/
Autor:
Emmanuel Donnadieu, Maik Luu, Miriam Alb, Brigitte Anliker, Silvia Arcangeli, Chiara Bonini, Biagio De Angelis, Rashmi Choudhary, David Espie, Anne Galy, Cam Holland, Zoltán Ivics, Chahrazade Kantari-Mimoun, Marie Jose Kersten, Ulrike Köhl, Chantal Kuhn, Bruno Laugel, Franco Locatelli, Ibtissam Marchiq, Janet Markman, Marta Angiola Moresco, Emma Morris, Helene Negre, Concetta Quintarelli, Michael Rade, Kristin Reiche, Matthias Renner, Eliana Ruggiero, Carmen Sanges, Hans Stauss, Maria Themeli, Jan Van den Brulle, Michael Hudecek, Monica Casucci
Publikováno v:
Donnadieu, E, Luu, M, Alb, M, Anliker, B, Arcangeli, S, Bonini, C, de Angelis, B, Choudhary, R, Espie, D, Galy, A, Holland, C, Ivics, Z, Kantari-Mimoun, C, Kersten, M J, Köhl, U, Kuhn, C, Laugel, B, Locatelli, F, Marchiq, I, Markman, J, Moresco, M A, Morris, E, Negre, H, Quintarelli, C, Rade, M, Reiche, K, Renner, M, Ruggiero, E, Sanges, C, Stauss, H, Themeli, M, van den Brulle, J, Hudecek, M & Casucci, M 2022, ' Time to evolve : predicting engineered T cell-associated toxicity with next-generation models ', Journal for Immunotherapy of Cancer, vol. 10, no. 5 . https://doi.org/10.1136/jitc-2021-003486
Despite promising clinical results in a small subset of malignancies, therapies based on engineered chimeric antigen receptor and T-cell receptor T cells are associated with serious adverse events, including cytokine release syndrome and neurotoxicit
Autor:
Silvia Arcangeli, Camilla Bove, Claudia Mezzanotte, Barbara Camisa, Laura Falcone, Francesco Manfredi, Eugenia Bezzecchi, Rita El Khoury, Rossana Norata, Francesca Sanvito, Maurilio Ponzoni, Beatrice Greco, Marta Angiola Moresco, Matteo G. Carrabba, Fabio Ciceri, Chiara Bonini, Attilio Bondanza, Monica Casucci
Publikováno v:
The Journal of Clinical Investigation
Chimeric antigen receptor (CAR) T cell expansion and persistence represent key factors to achieve complete responses and prevent relapses. These features are typical of early memory T cells, which can be highly enriched through optimized manufacturin
Autor:
Chiara F. Magnani, Marta Serafini, Maria Grazia Valsecchi, Tamás Raskó, Vincenzo Perriello, Ettore Biagi, Sarah Tettamanti, Gaia Alberti, Martino Introna, Zsuzsanna Izsvák, Maria Caterina Rotiroti, Felix Lundberg, Giuseppe Dastoli, Claudia Cappuzzello, Silvia Arcangeli, Chiara Buracchi, Amit Pande, Andrea Biondi, Stefania Galimberti
Publikováno v:
Mol Ther
The successful implementation of chimeric antigen receptor (CAR)-T cell therapy in the clinical context of B cell malignancies has paved the way for further development in the more critical setting of acute myeloid leukemia (AML). Among the potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35153ff5179c4306903743a815c275b4
https://hdl.handle.net/11391/1534501
https://hdl.handle.net/11391/1534501
Autor:
Sarah Tettamanti, Silvia Arcangeli, Andrea Biondi, Chiara F. Magnani, Luca Varani, Maria Caterina Rotiroti, Ettore Biagi, Luca Simonelli, Marco Bardelli
Publikováno v:
Molecular Therapy. 25:1933-1945
Chimeric antigen receptor (CAR)-redirected T lymphocytes are a promising immunotherapeutic approach and object of pre-clinical evaluation for the treatment of acute myeloid leukemia (AML). We developed a CAR against CD123, overexpressed on AML blasts
Autor:
Monica Casucci, Attilio Bondanza, Vincenzo Perriello, Andrea Biondi, Silvia Arcangeli, Ettore Biagi, Sarah Tettamanti, Maria Caterina Rotiroti
Publikováno v:
Human Gene Therapy. 28:231-241
Acute myeloid leukemia (AML) still represents an unmet clinical need for adult and pediatric high-risk patients, thus demanding advanced and personalized therapies. In this regard, different targeted immunotherapeutic approaches are available, rangin
Publikováno v:
Translational Cancer Research. 5:S174-S177